RheoGene, Genomatix Sign Agreement to Provide RheoSwitch

RheoGene announced that it has granted a nonexclusive worldwide license to Genomatix to produce custom DNA vectors that incorporate RheoGene's RheoSwitch inducible gene regulation technology. The agreement also grants RheoGene nonexclusive rights to use the Genomatix UltraVector production system for RheoGene's ongoing research and development of advanced gene regulation technologies and therapeutic products.

Market Wire (http://www.marketwire.com/mw/release_html_b1?release_id=82703)